The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: metoclopramide     Quarter: 2016Q3

Total Records: 411     Number of Pages: 21

DRUGNAME PT EventCount
METOCLOPRAMIDE TEVA Product physical issue 1
METOCLOPRAMIDE. Abdominal distension 1
METOCLOPRAMIDE. Abdominal pain upper 1
METOCLOPRAMIDE. Activated partial thromboplastin time shortened 1
METOCLOPRAMIDE. Activities of daily living impaired 1
METOCLOPRAMIDE. Acute respiratory distress syndrome 1
METOCLOPRAMIDE. Acute sinusitis 1
METOCLOPRAMIDE. Adjustment disorder with mixed anxiety and depressed mood 1
METOCLOPRAMIDE. Adrenal insufficiency 1
METOCLOPRAMIDE. Aggression 1
METOCLOPRAMIDE. Agitation 1
METOCLOPRAMIDE. Alanine aminotransferase increased 1
METOCLOPRAMIDE. Analgesic drug level increased 1
METOCLOPRAMIDE. Anuria 1
METOCLOPRAMIDE. Aortic dissection 1
METOCLOPRAMIDE. Aspartate aminotransferase increased 1
METOCLOPRAMIDE. Balance disorder 1
METOCLOPRAMIDE. Bezoar 1
METOCLOPRAMIDE. Blood alkaline phosphatase increased 1
METOCLOPRAMIDE. Blood cholesterol increased 1

Total Records: 411     Number of Pages: 21